Kurt Von Emster

Insider Reports History

Location
601 Gateway Boulevard, Suite 350, San Francisco, CA
Signature
By: /s/ Herb Cross, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kurt Von Emster:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vera Therapeutics, Inc. Director Class A Common Stock 2.96M $53.3M $18.00 May 18, 2021 Indirect
Vera Therapeutics, Inc. Director Class A Common Stock 17.8K $321K $18.00 May 17, 2021 Direct
CymaBay Therapeutics, Inc. Director Common Stock 0 $0 $2.94 Mar 22, 2024 Direct
Vaxcyte, Inc. Director Stock option (right to buy) 15K Jun 2, 2021 Direct
Vera Therapeutics, Inc. Director Stock Option (right to buy) 9.93K May 13, 2021 Direct
Jasper Therapeutics, Inc. Director Stock Option (right to buy) 7.5K Jul 3, 2025 Direct
CymaBay Therapeutics, Inc. Director Stock Appreciation Right 0 Sep 29, 2023 Direct
CymaBay Therapeutics, Inc. Director Employee Stock Option (right to buy) 0 Mar 22, 2024 Direct
Vera Therapeutics, Inc. Director Series C Preferred Stock 0 May 18, 2021 Indirect

Insider Reports Filed by Kurt Von Emster

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JSPR Jasper Therapeutics, Inc. Jul 3, 2025 1 $0 4 Jul 3, 2025 Director
JSPR Jasper Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
CBAY CymaBay Therapeutics, Inc. Mar 22, 2024 13 $0 4 Mar 22, 2024 Director
CBAY CymaBay Therapeutics, Inc. Jan 24, 2024 1 $0 4 Jan 26, 2024 Director
CBAY CymaBay Therapeutics, Inc. Sep 29, 2023 6 -$170K 4 Sep 29, 2023 Director
JSPR Jasper Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
JSPR Jasper Therapeutics, Inc. Apr 13, 2023 1 -$13.5K 4 Apr 14, 2023 Director
CBAY CymaBay Therapeutics, Inc. Jan 25, 2023 1 $0 4 Jan 27, 2023 Director
JSPR Jasper Therapeutics, Inc. Oct 12, 2022 1 $0 4 Oct 13, 2022 Director
JSPR Jasper Therapeutics, Inc. Mar 21, 2022 1 $0 4 Mar 23, 2022 Director, 10%+ Owner
CBAY CymaBay Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 Director
JSPR Jasper Therapeutics, Inc. Sep 24, 2021 0 $0 3 Oct 1, 2021 Director, 10%+ Owner
PCVX Vaxcyte, Inc. Jun 2, 2021 1 $0 4 Jun 3, 2021 Director
VERA Vera Therapeutics, Inc. May 17, 2021 4 $8.71M 4 May 18, 2021 Director
VERA Vera Therapeutics, Inc. May 13, 2021 1 $0 4 May 17, 2021 Director, 10%+ Owner
VERA Vera Therapeutics, Inc. May 13, 2021 0 $0 3 May 13, 2021 Director, 10%+ Owner